[Application Areas of Artificial Intelligence in the Context of One Health with A focus on Antimicrobial Resistance]

Overview

Journal Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz

Publisher Springer

Specialty Public Health

Date 2023 May 4

PMID 37140603

Authors

Christopher Irrgang

Tim Eckmanns

Max V Kleist

Esther-Maria Antao

Katharina Ladewig

Lothar H Wieler

Nils Korber

Affiliations

Soon will be listed here.

Abstract

Societal health is facing a number of new challenges, largely driven by ongoing climate change, demographic ageing, and globalization. The One Health approach links human, animal, and environmental sectors with the goal of achieving a holistic understanding of health in general. To implement this approach, diverse and heterogeneous data streams and types must be combined and analyzed. To this end, artificial intelligence (AI) techniques offer new opportunities for cross-sectoral assessment of current and future health threats. Using the example of antimicrobial resistance as a global threat in the One Health context, we demonstrate potential applications and challenges of AI techniques.This article provides an overview of different applications of AI techniques in the context of One Health and highlights their challenges. Using the spread of antimicrobial resistance (AMR), an increasing global threat, as an example, existing and future AI-based approaches to AMR containment and prevention are described. These range from novel drug development and personalized therapy, to targeted monitoring of antibiotic use in livestock and agriculture, to comprehensive environmental surveillance.

References

Westphal-Settele K, Konradi S, Balzer F, Schonfeld J, Schmithausen R . [The environment as a reservoir for antimicrobial resistance : A growing problem for public health?]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61(5):533-542. DOI: 10.1007/s00103-018-2729-8. View

Dragano N, Gerhardus A, Kurth B, Kurth T, Razum O, Stang A . [Public Health: Setting Goals, Establishing Structures and Improving Health for All]. Gesundheitswesen. 2016; 78(11):686-688. DOI: 10.1055/s-0042-116192. View

Rodriguez-Mozaz S, Vaz-Moreira I, Varela Della Giustina S, Llorca M, Barcelo D, Schubert S . Antibiotic residues in final effluents of European wastewater treatment plants and their impact on the aquatic environment. Environ Int. 2020; 140:105733. DOI: 10.1016/j.envint.2020.105733. View

Fisher M, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell E, Bowyer P . Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022; 20(9):557-571. PMC: 8962932. DOI: 10.1038/s41579-022-00720-1. View

Schweickert B, Feig M, Schneider M, Willrich N, Behnke M, Pena Diaz L . Antibiotic consumption in Germany: first data of a newly implemented web-based tool for local and national surveillance. J Antimicrob Chemother. 2018; 73(12):3505-3515. DOI: 10.1093/jac/dky345. View

Boolchandani M, DSouza A, Dantas G . Sequencing-based methods and resources to study antimicrobial resistance. Nat Rev Genet. 2019; 20(6):356-370. PMC: 6525649. DOI: 10.1038/s41576-019-0108-4. View

Hufsky F, Lamkiewicz K, Almeida A, Aouacheria A, Arighi C, Bateman A . Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. Brief Bioinform. 2020; 22(2):642-663. PMC: 7665365. DOI: 10.1093/bib/bbaa232. View

Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bolton D, Bover-Cid S, Chemaly M . Transmission of antimicrobial resistance (AMR) during animal transport. EFSA J. 2022; 20(10):e07586. PMC: 9593722. DOI: 10.2903/j.efsa.2022.7586. View

Adedeji W . THE TREASURE CALLED ANTIBIOTICS. Ann Ib Postgrad Med. 2017; 14(2):56-57. PMC: 5354621. View

10.

Tetteh J, Matthaus F, Hernandez-Vargas E . A survey of within-host and between-hosts modelling for antibiotic resistance. Biosystems. 2020; 196:104182. DOI: 10.1016/j.biosystems.2020.104182. View

11.

Khoury M, Armstrong G, Bunnell R, Cyril J, Iademarco M . The intersection of genomics and big data with public health: Opportunities for precision public health. PLoS Med. 2020; 17(10):e1003373. PMC: 7595300. DOI: 10.1371/journal.pmed.1003373. View

12.

Baker R, Mahmud A, Miller I, Rajeev M, Rasambainarivo F, Rice B . Infectious disease in an era of global change. Nat Rev Microbiol. 2021; 20(4):193-205. PMC: 8513385. DOI: 10.1038/s41579-021-00639-z. View

13.

Semenza J, Paz S . Climate change and infectious disease in Europe: Impact, projection and adaptation. Lancet Reg Health Eur. 2021; 9:100230. PMC: 8513157. DOI: 10.1016/j.lanepe.2021.100230. View

14.

Ayobami O, Brinkwirth S, Eckmanns T, Markwart R . Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infect. 2022; 11(1):443-451. PMC: 8820817. DOI: 10.1080/22221751.2022.2030196. View

15.

Rodriguez-Gonzalez A, Zanin M, Menasalvas-Ruiz E . Public Health and Epidemiology Informatics: Can Artificial Intelligence Help Future Global Challenges? An Overview of Antimicrobial Resistance and Impact of Climate Change in Disease Epidemiology. Yearb Med Inform. 2019; 28(1):224-231. PMC: 6697502. DOI: 10.1055/s-0039-1677910. View

16.

LeCun Y, Bengio Y, Hinton G . Deep learning. Nature. 2015; 521(7553):436-44. DOI: 10.1038/nature14539. View

17.

de la Fuente-Nunez C . Antibiotic discovery with machine learning. Nat Biotechnol. 2022; 40(6):833-834. DOI: 10.1038/s41587-022-01327-w. View

18.

. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

19.

Rabinowitz P, Pappaioanou M, Bardosh K, Conti L . A planetary vision for one health. BMJ Glob Health. 2018; 3(5):e001137. PMC: 6169660. DOI: 10.1136/bmjgh-2018-001137. View

20.

Palinkas L, Wong M . Global climate change and mental health. Curr Opin Psychol. 2019; 32:12-16. DOI: 10.1016/j.copsyc.2019.06.023. View